2022 Annual Public Meeting

2022 Annual Public Meeting

May 16, 2022
2:30-4 PM Eastern

Each year, the Reagan-Udall Foundation for the FDA conducts an Annual Public Meeting of its Board of Directors to share its activities in support of the U.S. Food and Drug Administration. This meeting is open to the public, but advanced registration is required.

Commissioner Robert M. Califf, MD, highlighted FDA's key priorities. 

Evidence Accelerator: Diagnostics Lab Meeting

This month's Diagnostics Lab meeting we will look at LAMP-based diagnostics; Testing in the airline industry and air travel. We will hear presentations from Dr. Nilay Shah of Delta Airlines and Randy True of FloodLamp Biotechnologies.

This is the once-monthly COVID-19 Evidence Accelerator Diagnostics Lab Meeting. These meetings occur the third Thursday of every month at 12 pm ET. 

If you are interested in attending the meeting series please email  evidenceaccelerator@reaganudall.org.

COVID-19 Evidence Accelerator: Therapeutics/Vaccines Lab Meeting

 02/17/2022 - 03:00 PM

During our February Therapeutics/Vaccines Lab Meeting we will hear from colleagues at WHO and Gavi, TriNetX, and Kaiser Permanente California discuss ongoing vaccine research. Nevine Zariffa will also join us to discuss what we see in RCTs vs. RWD studies.

This is our once-monthly COVID-19 Evidence Accelerator Therapeutics/Vaccines Lab Meeting. These meetings occur the third Thursday of every month at 3pm ET.